News | Structural Heart | July 05, 2019

FEops HEARTguide Wins CSI Highlight of the Year Award

Software helps physicians evaluate device sizing and positioning pre-operatively for TAVI and left atrial appendage occlusion procedures

FEops HEARTguide Wins CSI Highlight of the Year Award

July 5, 2019 — FEops announced that FEops HEARTguide was the winning entry at CSI Frankfurt 2019 voted on by physician attendees for the Highlight of the year award in the interventional imaging category. This award celebrates promising technologies that will have the biggest impact in the field, on daily practice or on patients’ health and outlook. Cameron Dowling, M.D., St George’s, U.K., and Martin Swaans, M.D., Ph.D., St. Antonius, The Netherlands, shared their early experience with patient-specific computer simulation of transcatheter aortic valve implantation (TAVI) in bicuspid aortic valve morphology.

FEops HEARTguide, which received CE mark earlier this year, is a procedure planning environment for structural heart interventions that provides physicians unique insights to evaluate device sizing and positioning pre-operatively using novel computational modeling and simulation technology. The current release includes workflows for TAVI and left atrial appendage occlusion (LAAO) procedures.

In addition to the Highlight of the year award, FEops HEARTguide was also starring in two best poster awards at CSI: 

  • Best poster in TAVI, commented by Dowling and focusing on the impact of FEops HEARTguide on heart team decision making for TAVI in patients with bicuspid aortic valves; and 
  • Best poster in LAA Occlusion, where A. Bavo, FEops, Belgium, presented the validation data for the LAAO workflow within FEops HEARTguide. 

Dowling stated, “This award recognizes the outstanding work undertaken by the FEops team in developing patient-specific computer simulations for structural heart interventions.”

FEops HEARTguide cloud-based procedure planning environment uses advanced personalized computational modeling and simulation to provide clinicians and medical device manufacturers with insights into the interaction between transcatheter structural heart devices and specific patient anatomy – preoperatively. The current release includes TAVI and LAAO workflows. Such insights have the power to accelerate research and development of novel device-based solutions, as well as ultimately help to improve clinical outcomes in real-world hospital settings.

Read the article "FEops Closes Financing to Commercialize TAVIguide Service"

For more information: www.feops.com

Related Content

A large subgroup analysis of the VOYAGER PAD randomized clinical trial showed neither a mortality risk nor benefit associated with the use of paclitaxel drug-coated devices (DCD) in the treatment of peripheral artery disease (PAD). The study also found that the benefit of rivaroxaban use on reducing ischemic limb and cardiovascular outcomes was consistent regardless of whether a DCD was used. #TCT2020 #TCTconnect
Feature | Cath Lab | October 18, 2020
October 18, 2020 – A large subgroup analysis of a randomized clinical trial showed neither a mortality risk nor benef
A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin capped fibrous atheroma (TCFA). #TCTconnect #TCT2020

A longitudinal vessel assessment may demonstrate co-existence of multiple plaque morphologies on OCT, including superficial calcification with thrombus, healed plaque, plaque rupture, lipidic plaque with a thin cap fibro-atheroma (TCFA).

News | Cath Lab | October 18, 2020
October 18, 2020 – Data from the...
The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions. #TCT2-0

The DISRUPT CAD III study showed intravascular lithoplasty from Shockwave Medical was effective in breaking up calcified coronary lesions.

Feature | Cath Lab | October 16, 2020
October 15, 2020 — Shockwave Medical's Intravascular Lithotripsy (IVL) system to treat severely calcified coronary ar
Videos | Cath Lab | October 16, 2020
This is an example pf the Shockwave Medical Intravascular Lithotripsy (IVL) catheter system designed to break up heav
Videos | Cath Lab | July 15, 2020
Richard Botto, CVT, RCSA, chief cardiovascular technologist, division of cardiology, cardiac cath lab, offers an over
Videos | Cath Lab | July 13, 2020
The Vieussens’ arterial ring (VAR) is a connection between the conus artery and the left anterior descending (LAD) co
News | Cath Lab | July 06, 2020
July 6, 2020 — Black patients who undergo percutaneous coronary intervention (PCI) are at an increased risk for major
TCT cancels in-person meeting and goes virtual due to COVID-19
News | Cath Lab | May 27, 2020
May 27, 2020 — To ensure the health and safety of all attendees due to the ongoing COVID-19 (SARS-CoV-2) pandemic, th
Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, or nil per os (NPO), as there are no current standardized fasting protocols, but the CHOWNOW study found patients do not need to fast and will have similar outcomes. #SCAI2020
Feature | Cath Lab | May 18, 2020
May 18, 2020 – Patients undergoing cardiac catheterization are traditionally instructed to follow nothing by mouth, o